BRAVA CRT-D, CONCETO II CRT-D, CONSULTA ICD, MAXIMO II CRT-D, PROTECTA CRT-D, XT CRT-D, VIVA S CRT-D, XT CRT-D
FDA premarket approval P010031/S446 · decided 2014-06-17
Approval details
- PMA number
- P010031
- Supplement
- S446
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- BRAVA CRT-D, CONCETO II CRT-D, CONSULTA ICD, MAXIMO II CRT-D, PROTECTA CRT-D, XT CRT-D, VIVA S CRT-D, XT CRT-D
- Applicant
- Medtronic Cardiac Rhythm Disease Management
- Date received
- 2014-05-23
- Decision date
- 2014-06-17
- Days to decision
- 25 days
- Decision code
- OK30
- Advisory committee
- Cardiovascular
- Expedited review
- No
- Location
- Mounds View, MN
- Statement
- IMPROVEMENTS FOR THE PLASMA CLEANING PROCESS AT THE MANUFACTURING SITE AT MEDTRONIC PUERTO RICO OPERATIONS (MPROC) FOR THE DEVICES.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.